Bioactive Signaling in Next-Generation Pharmacotherapies for Heart Failure-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bioactive Signaling in Next-Generation Pharmacotherapies for Heart Failure

Published:2018-12-01 Issue:12 Volume:3 Page:1232
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Oatmen Kelsie E.¹,Zile Michael R.²³,Burnett John C.⁴,Spinale Francis G.¹⁵

Affiliation:

1. Cardiovascular Translational Research Center, University of South Carolina School of Medicine, Columbia

2. Medical University of South Carolina, Charleston

3. Ralph H. Johnson Department of VA Medical Center, Charleston, South Carolina

4. Cardiorenal Research Laboratory, Mayo Clinic, Rochester, Minnesota

5. William Jennings Bryan Dorn VA Medical Center, Columbia, South Carolina

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Reference172 articles.

1. Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study.;Packer;J Card Fail,2005

2. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.;Konstam;JAMA,2007

3. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.;Teerlink;Lancet,2013

4. Effect of nesiritide in patients with acute decompensated heart failure;O’Connor;N Engl J Med,2011

5. Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi).;Gu;J Clin Pharmacol,2010

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular Membrane‐Engineered Nanovesicles as a Three‐Stage Booster to Target the Lesion Core;Advanced Materials;2023-10-27

2. Sacubitril/valsartan: research progress of multi-channel therapy for cardiorenal syndrome;Frontiers in Pharmacology;2023-05-05

3. Sacubitril/valsartan attenuates myocardial ischemia/reperfusion injury via inhibition of the GSK3β/NF-κB pathway in cardiomyocytes;Archives of Biochemistry and Biophysics;2022-11

4. LCZ696 Attenuated Doxorubicin-Induced Chronic Cardiomyopathy Through the TLR2-MyD88 Complex Formation;Frontiers in Cell and Developmental Biology;2021-04-13

5. Neprilysin inhibition does not alter dynamic of proenkephalin‐A 119‐159 and pro‐substance P in heart failure;ESC Heart Failure;2021-03-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3